wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

PRCHTMLE_1MT-P2

Total questions: 124

Worksheet time: 1hrs 2mins

Name
Class
Date
1.
organs or tissues appear smaller THAN NORMAL
a)
Degenerative changes
b)
Retrogressive changes
c)
Progressive changes
2.
Inflammation characterized by the presence of large amount of pus:
a)
Serous
b)
Hemorrhagic
c)
Fibrinous
d)
Suppurative or purulent
3.
Inflammation characterized by extensive outpouring of a watery, low-protein fluid from blood:
a)
Serous
b)
Hemorrhagic
c)
Fibrinous
d)
Suppurative or purulent
4.
It is usually observed in skeletal muscles, heart, kidneys, endocrine organs and smooth muscles of hollow viscera due to increased workload and endocrine stimulation (e.g. during exercise and pregnancy)
a)
Compensatory hypertrophy
b)
False hypertrophy
c)
True hypertrophy
d)
None of these
5.
It is due to edema fluid and connective tissue proliferation (e.g. in cirrhosis and chronic hypertrophic salphingitis or appendicitis):
a)
Compensatory hypertrophy
b)
False hypertrophy
c)
True hypertrophy
d)
None of these
6.
Increase in size of an organ or tissue due to an increase in the number of cells resulting from growth of new cells:
a)
Hypoplasia
b)
Hypertrophy
c)
Atrophy
d)
Hyperplasia
7.
Marked regressive change in adult cells towards more primitive or embryonic cell types:
a)
Metaplasia
b)
Anaplasia
c)
Dysplasia
d)
Neoplasia
8.
Continuous abnormal proliferation of cells without control:
a)
Metaplasia
b)
Anaplasia
c)
Dysplasia
d)
Neoplasia
9.
Reversible change involving the transformation of one cell type to another:
a)
Metaplasia
b)
Anaplasia
c)
Dysplasia
d)
Neoplasia
10.
organs or tissues appear LARGER THAN NORMAL
a)
Degenerative changes
b)
Retrogressive changes
c)
Progressive changes
11.
Increased tissue size due to increased cell size.
a)
Degenerative changes
b)
Retrogressive changes
c)
Progressive changes
d)
Hypertrophy
e)
Hyperplasia
12.
Increased tissue size due to increased cell number.
a)
Degenerative changes
b)
Atrophy
c)
Progressive changes
d)
Hypertrophy
e)
Hyperplasia
13.
Refers to an increase in size of tissues or organs due to increase in size. NO NEW CELLS
a)
Degenerative changes
b)
Atrophy
c)
Progressive changes
d)
Hypertrophy
e)
Hyperplasia
14.
Refers to an acquired decrease in the size of a normally tissue or organ. REDUCTION IN CELL SIZE
a)
Degenerative changes
b)
Atrophy
c)
Progressive changes
d)
Hypertrophy
e)
Hyperplasia
15.
Tissues have abnormalities
a)
Degenerative changes
b)
Retrogressive changes
c)
Progressive changes
16.
Incomplete/defective development of a tissue/organ
a)
Aplasia
b)
Atresia
c)
Hypoplasia
d)
Agenesia
17.
This is most commonly seen in one paired structures like kidneys, gonads, and adrenals
a)
Aplasia
b)
Atresia
c)
Hypoplasia
d)
Agenesia
18.
Represented only by a mass of fatty or fibrous tissue
a)
Aplasia
b)
Atresia
c)
Hypoplasia
d)
Agenesia
19.
This has NO resemblance to the adult structure
a)
Aplasia
b)
Atresia
c)
Hypoplasia
d)
Agenesia
20.
Example is amastia
a)
Aplasia
b)
Atresia
c)
Hypoplasia
d)
Agenesia
21.
Complete non-appearance of an organ
a)
Aplasia
b)
Atresia
c)
Hypoplasia
d)
Agenesia
22.
Failure to form an opening
a)
Aplasia
b)
Atresia
c)
Hypoplasia
d)
Agenesia
23.
Failure of an organ to reach its full, mature size
a)
Aplasia
b)
Atresia
c)
Hypoplasia
d)
Agenesia
24.
Natural
a)
Physiologic atrophy
b)
Pathologic atrophy
c)
Brown atrophy
25.
This type of atrophy happens due to decreased work load
a)
Physiologic atrophy
b)
Pathologic atrophy
c)
Brown atrophy
26.
Thymus, brain, sex organs
a)
Physiologic atrophy
b)
Pathologic atrophy
c)
Brown atrophy
27.
Due to denervation of muscle; diminished blood supply
a)
Physiologic atrophy
b)
Pathologic atrophy
c)
Brown atrophy
28.
Refers to a decrease in size of an organ, usually as a consequence of disease
a)
Physiologic atrophy
b)
Pathologic atrophy
c)
Brown atrophy
29.
Lipofuscin
a)
Physiologic atrophy
b)
Pathologic atrophy
c)
Brown atrophy
30.
Due to lack of nutrition accumulated and reduced blood supply to an organ or tissue becomes reduced below critical level
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
31.
This basically happens as a result of reduced blood supply
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
32.
Persistent pressure of the tissue may directly injure the cells or may secondarily promote diminution of blood supply
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
33.
Basically happens as a result of persistent pressure
a)
Starvation or change atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
34.
Due to excessive narrowing supply may lead to wasting tissues
a)
Starvation or change atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
35.
Happens basically as a result of inactivity or diminished function
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
36.
inactivity or diminished function of a tissue or organ may lead go narrowing of blood vessels, with loss of nutrition atrophy occur
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
37.
Prolonged overwork, especially of an endocrine organ may produce enlargement with ultimate slow progressive loss of parenchymal cells
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
38.
prolonged overwork
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
39.
diminished or absent endocrine stimulation
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
40.
diminished or absent endocrine stimulation may produce functional atrophy
a)
Vascular atrophy
b)
Pressure atrophy
c)
Atrophy of disuse
d)
Exhaustion atrophy
e)
Endocrine atrophy
41.
Which of the following types of hypertrophy is usually seen in skeletal muscle, heart, kidneys, endocrine glands due to increased workload?
a)
True hypertrophy
b)
False hypertrophy
c)
Compensatory hypertrophy
42.
Which of the following types of hypertrophy is usually seen due to edema fluid and connective tissue proliferation?
a)
True hypertrophy
b)
False hypertrophy
c)
Compensatory hypertrophy
43.
Which of the following types of hypertrophy involves one of paired organs when the opposite organ has been removed?
a)
True hypertrophy
b)
False hypertrophy
c)
Compensatory hypertrophy
44.
Decrease in size of uterus
a)
Physiologic hypertrophy
b)
Pathologic hypertrophy
c)
Congenital hypertrophy
45.
Systemic hypertension
a)
Physiologic hypertrophy
b)
Pathologic hypertrophy
c)
Congenital hypertrophy
46.
Phenytoin-induced
a)
Physiologic hypertrophy
b)
Pathologic hypertrophy
c)
Congenital hypertrophy
47.
Glandular proliferation of the female breast, increase in size of uterus (pregnancy)
a)
Physiologic hyperplasia
b)
Pathologic hyperplasia
48.
Resulting from normal stimuli, hormonal such as hyperplasia of breast and uterus during pregnancy
a)
Physiologic hyperplasia
b)
Pathologic hyperplasia
49.
Stimulation of growth factors, excess hormonal stimulation, viral infection, nodular.
a)
Physiologic hyperplasia
b)
Pathologic hyperplasia
50.
Skin warts due to HPV
a)
Physiologic hyperplasia
b)
Pathologic hyperplasia
51.
Ex. Enlargement of one kidney
a)
Compensatory hyperplasia
b)
Pathologic hyperplasia
52.
Ex. Endometrial hyperplasia
a)
Compensatory hyperplasia
b)
Pathologic hyperplasia
53.
Reversible
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
54.
Reversible change involving transformation in one type of adult cell to another
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
55.
Ex. Ciliated pseudostratified columnar epithelium → stratified squamous epithelium (chronic smoker)
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
56.
It is the regressive alteration in adults cells manifested by variation in size, shape, and orientation. usually reversible as well and do not lead to tumor formation
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
57.
One type of adult cell ↔ Changes in structural components
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
58.
Also known as atypical hyperplasia
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
59.
Example is thickening of the cervical epithelia
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
60.
Undifferentiated cell
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
61.
This is IRREVERSIBLE and deemed as a criterion toward malignancy
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
62.
Adult cell > More primitive cells (release tumor markers)
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
63.
Usually used as a criterion toward malignancy; irreversible ulet-ulet, more primitive cells
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
64.
Continuous abnormal proliferation of the cells without control; no purpose or function
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
65.
Field of expertise ng mga oncologists
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
66.
Example is leukemia
a)
Metaplasia
b)
Dysplasia
c)
Anaplasia/ Dedifferentiation
d)
Neoplasia/tumor
67.
study of cancer
a)
Ocology
b)
Oncology
c)
Onocology
d)
Oncolocogy
68.
greek word which means ''new''
a)
neu
b)
neo
c)
noe
d)
neio
69.
Which of the following parts of the tumor involve active elements (tumor cells)?
a)
Parenchyma
b)
Stroma
70.
Which of the following parts of the tumor involve connective tissue framework?
a)
Parenchyma
b)
Stroma
71.
Do not produce death
a)
Benign tumors
b)
Malignant tumors
72.
Tumor is localized and doesn’t metastasize
a)
Benign tumors
b)
Malignant tumors
73.
“-oma”
a)
Benign tumors
b)
Malignant tumors
74.
Are those that DO NOT produce death. Again, tumor is localized and doesn't metastasize
a)
Benign tumors
b)
Malignant tumors
75.
Produce death eventually
a)
Benign tumors
b)
Malignant tumors
76.
Invasive and destroys adjacent areas
a)
Benign tumors
b)
Malignant tumors
77.
Will produce death eventually, however small they may be and wherever they may be located. Invasive and destroys adjacent areas.
a)
Benign tumors
b)
Malignant tumors
78.
Malignant neoplasms are collectively referre to as cancers. ; sarcoma
a)
Benign tumors
b)
Malignant tumors
79.
Sarcoma originates from
a)
Mesenchymal/CT
b)
Epithelial tissues
80.
Carcinoma originates from
a)
Mesenchymal/CT
b)
Epithelial tissues
81.
Tumor implants continuous with the primary tumour
a)
Hemostasis
b)
Metastasis
c)
Malignansis
d)
Homeostasis
82.
Most reliable feature of malignancy
a)
Hemostasis
b)
Metastasis
c)
Malignansis
d)
Homeostasis
83.
Cancer cells penetrate into blood vessels, lymphatic's and basal cavities providing opportunity to spread
a)
Hemostasis
b)
Metastasis
c)
Malignansis
d)
Homeostasis
84.
All neoplasms metastasize EXCEPT; glial cells and basal cell carcinoma
a)
True
b)
False
85.
Neoplasm penetrates into a natural field; most often in the peritoneal cavity
a)
Seedling with body cavities
b)
Lymphatic spread
c)
Hematogenous spread
86.
Most common pathway for carcinomas (epithelial)
a)
Seedling with body cavities
b)
Lymphatic spread
c)
Hematogenous spread
87.
Most common pathway for sarcomas (connective tissue)
a)
Seedling with body cavities
b)
Lymphatic spread
c)
Hematogenous spread
88.
cells (parenchyma) > supporting tissues (stroma)
a)
Medullary
b)
Scirrhous
89.
supporting tissues (stroma) > cells (parenchyma)
a)
Medullary
b)
Scirrhous
90.
Fibroma
a)
Benign
b)
Malignant
91.
Lipoma
a)
Benign
b)
Malignant
92.
Chondoma
a)
Benign
b)
Malignant
93.
Osteoma
a)
Benign
b)
Malignant
94.
Hemangioma
a)
Benign
b)
Malignant
95.
Leiomyoma
a)
Benign
b)
Malignant
96.
Rhabdomyoma
a)
Benign
b)
Malignant
97.
Fibrosarcoma
a)
Benign
b)
Malignant
98.
Liposarcoma
a)
Benign
b)
Malignant
99.
Chondrosarcoma
a)
Benign
b)
Malignant
100.
Osteogenic sacrcoma
a)
Benign
b)
Malignant
101.
Hemangiosarcoma
a)
Benign
b)
Malignant
102.
Leukemia
a)
Benign
b)
Malignant
103.
Lymphoma
a)
Benign
b)
Malignant
104.
Leiomyosarcoma
a)
Benign
b)
Malignant
105.
Rhabdomyosarcoma
a)
Benign
b)
Malignant
106.
benign in hematopoietic cells
a)
Hemangioma
b)
Leukemia
c)
Fibroma
d)
Lymphoma
e)
NOTA
107.
benign in lymphoid tissues
a)
Hemangioma
b)
Leukemia
c)
Fibroma
d)
Lymphoma
e)
NOTA
108.
malignancy in hematopoietic cells
a)
Hemangioma
b)
Leukemia
c)
Fibroma
d)
Lymphoma
e)
NOTA
109.
Benign: Squamous cell papilloma; malignant squamous cell carcinoma
a)
Stratified squamous
b)
Glands and ducts
c)
Renal epithelium
110.
Benign: Adenoma; Malignant: Adenocarcinoma
a)
Stratified squamous
b)
Glands and ducts
c)
Renal epithelium
111.
Benign: Renal tubular adenoma ; Malignant: Renal cell carcinoma
a)
Stratified squamous
b)
Glands and ducts
c)
Renal epithelium
112.
Benign: Liver cell adenoma; malignant: hepatocarcinoma
a)
Bone liver cells
b)
Neuroectoderm
c)
Testicular epithelium
113.
Benign: Nevus/Mole; Malignant: Melanoma (melanocarcinoma)
a)
Bone liver cells
b)
Neuroectoderm
c)
Testicular epithelium
114.
Malignant: Seminoma
a)
Bone liver cells
b)
Neuroectoderm
c)
Testicular epithelium
115.
Benign tumor originating in stratified squamous
a)
Squamous cell papilloma
b)
Squamous cell carcinoma
c)
Adenoma
d)
Adenocarcinoma
116.
Malignant tumor originating in stratified squamous
a)
Squamous cell papilloma
b)
Squamous cell carcinoma
c)
Adenoma
d)
Adenocarcinoma
117.
Malignant tumor originating in Glands and ducts
a)
Squamous cell papilloma
b)
Squamous cell carcinoma
c)
Adenoma
d)
Adenocarcinoma
118.
Benign tumor originating in Glands and ducts
a)
Squamous cell papilloma
b)
Squamous cell carcinoma
c)
Adenoma
d)
Adenocarcinoma
119.
Benign tumor originating in renal epithelium
a)
Renal tubular adenoma
b)
Renal cell carcinoma
c)
Liver cell adenoma
d)
Hepatocarcinoma or hepatoma
120.
Malignant tumor originating in renal epithelium
a)
Renal tubular adenoma
b)
Renal cell carcinoma
c)
Liver cell adenoma
d)
Hepatocarcinoma or hepatoma
121.
Neuroectoderm benign tumor
a)
Nevus or mole
b)
Melanoma or melanocarcinoma
c)
Seminoma
d)
NOTA
122.
Neuroectoderm malignant tumor
a)
Nevus or mole
b)
Melanoma or melanocarcinoma
c)
Seminoma
d)
NOTA
123.
Testicular epithelium malignant tumor
a)
Nevus or mole
b)
Melanoma or melanocarcinoma
c)
Seminoma
d)
NOTA
124.
Testicular epithelium benign tumor
a)
Nevus or mole
b)
Melanoma or melanocarcinoma
c)
Seminoma
d)
NOTA